COMPLETE Guide For Chemotherapy Effects and It's Treatment

COP Chemo

COP chemotherapy is treatment to cure multiple myeloma and chronic lymphocytic leukemia. COP chemotherapy is combination chemotherapy cycloposphamide, vincristine sulfate and prednisone are used to in which three chemotherapy drugs including eradicate cancer.

Single Drug Chemotherapy

Single drug chemotherapy is not effective in treating chronic lymphocytic leukemia. Therefore combination chemotherapy regimen is applied to treat prolonged, advanced leukemia patients with increasing adenopathy, splenomegaly and anemia. Combination chemotherapy used is known as COP chemotherapy. It includes cycloposphamide, vincristine sulfate and prednisone for treating patients with chronic lymphocytic leukemia. COP is an effective and well tolerated therapy for advanced chronic lymphocytic leukemia.

COP

COP chemotherapy is also used to treat multiple myeloma.Before the use off alkylating agents for treating multiple myeloma,survival period of patient was very less (less than 1 year). Before COP chemotherapy, combination of melphalan and prednisoneis the standard regimen for multiple myeloma for more than two decades with median survival ranging from 2 to 3 years. When COP chemotherapy is used to treat multiple myeloma, it is more effective than MP (melphalan and prednisone) chemotherapy.Cyclophosphamide has therapeutic activity in treating multiple myeloma and also vincristine is an effective agent in the treatment.

COP chemotherapy is given in cycles

Mostly alternating chemotherapy which contains COP regimen and MP regimen is applied to treat multiple myeloma. Cycle is repeated after seven weeks. Each cycle contain rest period which allows patient to recover from side effects associated with chemotherapy. During COP-BLAM IA and IB chemotherapy, drugs are easily administered on an outpatient basis which produces complete remissions with long term, disease free survival. COP-BLAM III is an outgrowth of studies of infusional therapy. COD-BLAM IV chemotherapy treats patients four sequential cycles of infusional chemotherapy. In this treatment, high-dose alternating myelosuppressives (doxorubicin, cyclophosphamide), and cycle-active agents (methotrexate, cytarabine, and etoposide) are used. While in COP-BLAM V chemotherapy, four to six sequential cycles of infusional chemotherapy are applied to increase the rapidity of response. Though COP-BLAM IV chemotherapy treatment is shortened, it is very effective. However, effectiveness of treatment is also depends on age, prognosis and overall health of patient.

COP chemotherapy (cyclophosphamide, vincristine and prednisone) along with BLAM (bleomycin, doxorubicin and procarbazine) is combination chemotherapy to treat patient with large cell lymphoma. It is also known as COP-BLAM chemotherapy. There are different chemotherapy regimens including COP-BLAM IA, IB, III, IV and V. In original COP-BLAM chemotherapy treatment, multidrug therapy is administered intensely to kill tumor.

During COP-BLAM IA and IB chemotherapy, drugs are easily administered on an outpatient basis which produces complete remissions with long term, disease free survival. COP-BLAM III is an outgrowth of studies of infusional therapy. COD-BLAM IV chemotherapy infusional chemotherapy. In this treatment, high-dose alternating myelosuppressives (doxorubicin, cyclophosphamide), and cycle-active agents (methotrexate, cytarabine, and etoposide) are used. While in COP-BLAM V chemotherapy, four to six sequential cycles of infusional chemotherapy are applied to increase the rapidity of response. Though COP-BLAM IV chemotherapy treatment is shortened, it is very effective. However, effectiveness of treatment is also depends on age, prognosis and overall health of patient. treats patients four sequential cycles.